Cardiac computerized tomography (CT) has evolved from a research tool to an important diagnostic investigation in cardiology, and is now recommended in European, US, and UK guidelines. This review is designed to give the reader an overview of the current state of cardiac CT. The role of cardiac CT is multifaceted, and includes risk stratification, disease detection, coronary plaque quantification, defining congenital heart disease, planning for structural intervention, and, more recently, assessment of ischemia. This paper addresses basic principles as well as newer evidence.
INTRODUCTION
In the modern era, cardiac computerized tomography (CT) provides a robust non-invasive assessment of coronary artery disease (CAD) with a high degree of accuracy [1, 2] . It is capable of providing anatomical information about plaque stenosis and composition, and is now recommended in national guidelines [3] [4] [5] . Its beginnings, however, were humble, and mainly of an exploratory nature. The evolution of cardiac CT is directly proportional to the growing clinical demand for better imaging and the technological improvements seen with successive generations of scanners. This continuous evolution has now enabled coronary assessment with a high degree of accuracy at low levels of radiation for both acute and stable lesions [6, 7] . A CS is obtained using a non-enhanced scan that produces a series of stacked transaxial images, which is associated with relatively low radiation exposure [12, 13] . Agatston scores are now calculated using a semi-automated analysis package validated algorithm. risk of future cardiovascular events [14] [15] [16] [17] . A strong link has also been shown between CS and both regional left ventricular wall motion abnormalities and active ischemia [18, 19] . The CS has also been used extensively in asymptomatic screening, and has been incorporated into US guidelines as the tool of choice for absolute CAD risk assessment in asymptomatic adults [20] . Studies have shown that a CS of zero in asymptomatic patients indicates an excellent prognosis, regardless of traditional risk factors [21, 22] . The absence of calcium seems to confer reasonable longevity of protection against the risk of CAD, with previous research reporting approximately 80% of patients still having a score of zero at 4-5 years, although 1% had scores [100 [23] .
CORONARY CALCIUM SCORE
Asymptomatic individuals with a CS of zero were found to be at very low risk of future cardiovascular events (\1%), whereas the risk of a CAD event was threefold greater among those with a minimal CS (1-10) [24] . As such, some have claimed that a CS of zero is the most powerful negative risk factor for near-and medium-term development of coronary events among asymptomatic adults [25] . Results of the large Multi-Ethnic Study of Atherosclerosis (MESA) trial have suggested that a doubling of CS over time increased the estimated probability of coronary events by approximately 25% [26] .
Although the CS reflects the coronary atherosclerotic plaque burden, the absence of calcification does not completely rule out obstructive CAD. Non-calcified potentially vulnerable plaque will not be identified with the use of the CS [27] . The incidence of significant CAD in the absence of calcium seems to be dependent on factors of ethnicity, age, and presentation [28] , but has been quoted around 2-5% [29, 30] . In the absence of calcium but in the case of clinical concern, as demonstrated through clinical prediction scores, the use of coronary CTA may still be necessary for the assessment of non-calcified atherosclerotic plaques and the degree of coronary stenosis [31] .
COMPUTERIZED TOMOGRAPHY CORONARY ANGIOGRAPHY
In the 1970s, attempts were made to image coronary arteries using CT, but the effects of rapid cardiac motion and long acquisition times resulted in images of poor quality, with no practical value. In the 1980s, the detection of coronary arteries was possible, but the identification of stenosis for clinical purposes was not [32, 33] . Consequently, cardiac coronary CTA was virtually abandoned for a long period, and was seen as nothing more than a research In particular, it has demonstrated high negative predictive value, ranging from 98% to 100% reliability, in excluding CAD [36] [37] [38] . The ability of cardiac CT to detect significant coronary stenoses has been validated against conventional coronary angiography and intravascular ultrasound [36] [37] [38] [39] [40] . The evolution of this imaging technology has continued, with the number of detectors increasing, resulting in the wide availability of 128-, 256-, and 320-detector row scanners in clinical practice [41, 42] . This progression is ongoing, with 640-detector row scanners now citing even less radiation and scanning time, as well as improved image quality [43] .
Coronary CTA has the capacity to visualize the coronary arteries without the risks associated with invasive assessment. It can provide comprehensive information regarding coronary anatomy, the presence of obstructive and non-obstructive CAD, and plaque characteristics. This information can be used to predict long-term outcomes, as both plaque burden and non-obstructive disease have been associated with adverse prognosis [44] [45] [46] .
Conversely, the prognosis is excellent in the absence of disease. A meta-analysis by Hulten et al. [47] , in which 9592 patients were evaluated over a median follow-up of 20 months, found that the absence of CAD on coronary CTA was associated with a 0.17% annual rate of major adverse cardiac events, compared to 8.8% among patients with obstructive disease.
Coronary CTA is performed by the injection of contrast into a peripheral vein, and images are obtained when the contrast reaches the coronary arteries (Fig. 3) . The images are Retrospectively gated studies use X-ray beams throughout the R-R interval. This was traditionally associated with a high level of radiation in full-dose retrospective studies (Fig. 4) . It is now common practice, however, to use ECG dose modulation, which increases the dose of radiation around 75% along the R-R cycle in order to optimize the image without constant high levels of radiation. Retrospective studies use spiral scanning during table motion and more traditional cone beam reconstruction [48] . This offers the ability to reconstruct images at various time points, potentially creating greater diagnostic reassurance, and also the ability to assess left ventricular function.
However, despite ECG dose modulation, retrospective studies are still associated with a higher radiation dose than prospective studies.
Prospective studies use forward prediction of R wave timing, with no table motion during imaging, and non-spiral acquisition [49] . Here, After the raw scan data have been acquired, post-processing to remove abnormal heartbeats can improve suboptimal images. were not present in stable angina patients [50] .
ANALYSIS OF PLAQUE CHARACTERISTICS
In further work by the same author, which followed over 1000 patients who experienced an ACS event post-coronary CTA, again found that PR and LAP were predictors of ischemia culprit lesions [51] . More recent work, also by 
CARDIAC COMPUTED TOMOGRAPHY RADIATION
Although the diagnostic importance of CT is undisputed, it does expose patients to radiation, and thus the worry of malignancy [59] . In general, CT is estimated to account for approximately 50-70% of radiology-induced radiation exposure overall, but only 15% of all radiological examinations [60] . The number of cardiac investigations using radiation is also rising more rapidly than non-cardiac methods [61] . The concern with radiation is particularly high in cardiac patients given the potential cumulative dose that repeated investigations and therapy may produce. Radiation-induced cancers cannot be distinguished from other tumors, and consequently it is only by epidemiological studies that the rate of radiation-induced cancer can be detected. The exact degree to which imaging radiation exposure contributes to cancer remains unknown [62] , but research has suggested that there is no increased cancer risk associated with radiation exposure less than 20 mSv [63] . Levels of radiation exposure from cardiac CT were initially very high, with previous studies quoting 55.6 mSv for a 16-slice scanner before tube current modulation [64] , but levels with current scan technology have been cited as sub-1 mSv [65] . itself suggests, these effects are more random in nature, likely the result of long-term events and not a definite physical outcome. The higher the dose absorbed, the higher the likelihood of an event, although the dose received does not predict the severity of the effect. As such, stochastic effects are seen as independent of the absorbed dose and follow a linear no-threshold hypothesis. The two common types of stochastic effects are malignancies and heritable disease in offspring [62] . Cancers post-exposure have a latency period thought to be approximately 5-10 years for solid tumors and 2 years for leukemia [69] .
For years, physicians have battled with the issue of image quality versus radiation dose. The past few years have witnessed unprecedented advances in reducing radiation exposure, with now standard practices such as retrospective tube dose modulation and prospective axial ECG-triggered gated image acquisition [70, 71] .
Other methods include individualized protocol selection, bismuth breast shields [35] , and the rebirth of iterative reconstruction [72] [73] [74] .
LIMITATIONS OF CARDIAC COMPUTED TOMOGRAPHY
In addition to radiation exposure, there are several other limitations of cardiac CT. The 64-detector system takes a number of cardiac cycles to acquire images, and as such is prone to patient motion, arrhythmias, and patient breath-hold failure, which can produce motion artefacts and diagnostic uncertainty. Newer 256-and 320-detector scanners with faster gantry rotation times, increased X-ray tube power, and shorter scanning time have improved, but not eliminated, this tendency for artefacts. Other issues with cardiac CT include the need for beta-blockers and sublingual nitrate, potential allergic contrast reactions, poor contrast filling of distal vessels resulting in diagnostic uncertainty, and contrast-induced renal toxicity.
In comparison to invasive angiography, cardiac CT frequently overestimates the degree of coronary stenosis. There are several reasons for this. First, the presence of coronary calcium can cause blooming artefacts, increasing the perceived level of stenosis. Second, the potential for motion artefacts can make lumen assessment difficult. Third, inherent differences exist between the two techniques, with invasive angiography allowing the assessment of lumen with precise classification of stenosis, while CT is a tomographic approach that provides an estimate of overall plaque burden [75] . respectively [75] . The excellent capacity of CT for excluding disease means that it is recommended in low-to medium-risk patients
THE FUTURE OF CARDIAC COMPUTED TOMOGRAPHY
There is a large body of published studies involving other uses of coronary CTA not previously mentioned, such as in structural heart disease intervention [76] , bypass graft assessment [77] , congenital heart disease [78] , and acute chest pain [79, 80] . These well-established indications, together with UK, US, and European guidelines now advocating its use [3-5], will ensure that cardiac CT adoption will continue to grow.
Recent studies comparing cardiac CT with functional tests have shown equivalent if not better outcomes [81] [82] [83] . Moreover, the number of cardiac CT studies published in cardiology journals is also increasing, with CT research surpassing nuclear cardiology reports within the last 5 years [84] . Coronary CTA has also come to the fore as having the potential to become a complete imaging approach, with the ability to combine anatomical and functional imaging techniques. The potential for functional capacity has been seen in both CT perfusion imaging [85] and CT fractional flow reserve (FFR) [86, 87] . 
